Exploration of the system for cadaver kidney transplantation with the non-heart-beating donor: efficacy of in situ cooling and low-dose cyclosporine.

To expand the indication for the cadaveric kidney donor, the reduction of prolonged warm ischemic damage is the most important factor. We believe that the restriction of warm ischemic damage will be decreased by using the ISC procedure and low-dose CyA regimen.